Target RWE, a leading real-world evidence solutions company, today announced the results of an innovative research study validating the new nomenclature for fatty liver disease in pediatric patients.
KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...